KathleenLPostonMDMS(She/Her)

Neurology • Palo Alto, CA

Movement Disorder, Neuroimaging, Neurophysiology

Chief, Movement Disorders Professor, Neurology and Neurological Sciences Stanford University

Join to view full profile

Dr. Poston is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Poston's full profile

Already have an account?

Office
300 Pasteur Dr
Palo Alto, CA 94305

Education & Training

University of California (San Francisco)Residency, Neurology, 2003 - 2006
University of California (San Francisco)Residency, Internal Medicine, 2002 - 2005
Vanderbilt University School of MedicineClass of 2002

Certifications & Licensure

CA State Medical License 2004 - 2025
NY State Medical License 2006 - 2008
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Publications & Presentations

PubMed

33 citations
Distinct alterations in Parkinson's medication-state and disease-state connectivity.
Bernard Ng, Gaël Varoquaux, Jean-Baptiste Poline, Bertrand Thirion, Michael D. Greicius
Neuroimage. Clinical. 2017-01-01
283 citations
The Parkinson's progression markers initiative (PPMI): establishing a PD biomarker cohort
Kenneth Marek, Sohini Chowdhury, Andrew Siderowf, Shirley Lasch, Christopher S. Coffey
Annals of Clinical and Translational Neurology. 2018-10-31
15 citations
Substantia Nigra Volume Dissociates Bradykinesia and Rigidity from Tremor in Parkinson's Disease: A 7 Tesla Imaging Study.
Kathleen L. Poston, Matthew A.I. Ua Cruadhlaoich, Laura F. Santoso, Jeffrey D. Bernstein, Tian Liu
Journal of Parkinson's Disease. 2020-01-01

Press Mentions

Lilly’s Alzheimer’s Drug a Step Closer to Final FDA NodJune 19th, 2024
University of Southern California Institute Launches Worldwide Study of Parkinson’s DiseaseSeptember 11th, 2021
Guest View: When Dementia Comes KnockingJune 18th, 2020
Join now to see all

Professional Memberships